Literature DB >> 26411995

Validation and evaluation of new assessments for the otolaryngology undergraduate medical clerkship.

R Woods1, T Subramaniam1, A Patterson2, M Hennessy2, C Timon1.   

Abstract

OBJECTIVES: To validate and evaluate a short answer question paper and objective structured clinical examination. Validity and effect on overall performance were considered.
METHODS: Students completed a voluntary short answer question paper during their otolaryngology attachment. Short answer question paper results were collated and compared to the essay examination and new end of year objective structured clinical examination.
RESULTS: The study comprised 160 students. Questions were validated for internal consistency (Cronbach's alpha = 0.76). Correlations were determined for: short answer question paper and essay results (r = 0.477), short answer question paper and objective structured clinical examination results (r = 0.355), and objective structured clinical examination and essay results (r = 0.292). On unpaired t-tests comparing the short answer question paper group and non-short answer question paper group, essay results were 1.2 marks higher (p = 0.45) and the objective structured clinical examination results were 0.09 marks lower (p = 0.74) in the short answer question paper group.
CONCLUSION: Two new valid summative assessments of student ability have been introduced, which contribute to an enhanced programme of assessment to drive student learning.

Keywords:  Clinical Clerkship; Education; Educational Assessment; Examination Questions; Medical; Otolaryngology; Reliability And Validity; Undergraduate

Mesh:

Year:  2015        PMID: 26411995     DOI: 10.1017/S002221511500242X

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  1 in total

1.  Prospective audit of a dedicated ear, nose and throat emergency department and 24-year comparison.

Authors:  R S R Woods; E Keane; C V Timon; S Hone
Journal:  Ir J Med Sci       Date:  2016-01-29       Impact factor: 1.568

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.